UBL5 and neoplasm: Furthermore, the stable UBL5 KD cells became poorly tumorigenic after implantation to immunodeficient NOD scid gamma mice compared with the Ctrl-shRNA-transduced cells (Fig. 5C), indicating that proper expression of UBL5 is required for the survival of these tumor cells in vivo.